proteosome vaccine การใช้

• Several vaccine candidates for " Shigella " are in various stages of development including live attenuated, conjugate, ribosomal, and proteosome vaccines . " Shigella " has been a longstanding World Health Organization target for vaccine development, and sharp declines in age-specific diarrhea / dysentery attack rates for this pathogen indicate that natural immunity does develop following exposure; thus, vaccination to prevent the disease should be feasible.